Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Trovagene to Present New Data from Onvan...||08/15/19|
|SAN DIEGO , Aug. 15, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company, ...|
|Trovagene Announces Second Quarter 2019 ...||08/08/19|
|SAN DIEGO , Aug. 8, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage Precision Cancer Medicine™ company, developing drugs that ta...|
|Date||2019-08-08 (AMC)||Est. (EPS/Rev.)||($0.53)/ 180K|
|Actual (EPS/Rev.)||$-0.79/ $138.00 K||EPS (TTM)||0|